Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07650149 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetic, Microbiological and Behavioral Factors in Obesity

Study acronym: OPTIMIZE-GEN
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 15 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will assess the impact of genetic markers, microbiological (microbiome) and behavioral factors on tolerance, adherence and effectiveness of dual GLP1/GIP RA in the treatment of obesity. 200 consecutive patients who meet all inclusion and none of the exclusion criteria will be enrolled.
Trial Details
NCT Number NCT07650149
Lead Sponsor Jan Kochanowski University
Collaborators: LUX MED Group
Conditions
(from sponsor)		 Obesity & Overweight, Obesity, Genetics
Related terms Obesity, Overweight, Patient Compliance
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov